Company intelligence / Profile preview

Jiangsu Jiye Biopharmaceutical

Ownership: Private
Development stage: Other

Overview

Jiangsu Jiye Biopharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of innovative small molecule drugs, particularly in the metabolic and endocrine therapeutic areas. The company operates out of the China Medical City in Taizhou, Jiangsu province, leveraging a robust R&D infrastructure to advance its pipeline of treatments for chronic diseases. Its lead programs include novel GLP-1 receptor agonists and DPP-4 inhibitors aimed at addressing the growing prevalence of type 2 diabetes and obesity. Jiangsu Jiye Biopharmaceutical integrates drug discovery with clinical development to bring high-quality, affordable therapeutic options to the global market.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Jiye Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Jiye Biopharmaceutical.

Explore the full profile